Krt6a-Positive Mammary Epithelial Progenitors Are Not at Increased Vulnerability to Tumorigenesis Initiated by ErbB2

While most breast cancers are thought to arise from the luminal layer of the breast tissue, it remains unclear which specific cells in the luminal layer are the cells of origin of breast cancer. We have previously reported that WAP-positive luminal epithelial cells are at increased susceptibility to tumor initiation by ErbB2 compared to the bulk population, while the mammary cells with canonical Wnt signaling activity fail to evolve into tumors upon ErbB2 activation. Here, we used retrovirus to introduce ErbB2 into the Krt6a-positive mammary progenitor subset of the luminal epithelium and, for comparison, into the mammary luminal epithelium indiscriminately. Tumors developed from both groups of cells with a similar latency. These data indicate that the Krt6a-positive subset of mammary epithelial cells can be induced to form cancer by ErbB2 but it is not more susceptible to tumorigenesis initiated by ErbB2 than the bulk population of the luminal epithelium.

[1]  K. Wagner,et al.  Parity-induced mouse mammary epithelial cells are pluripotent, self-renewing and sensitive to TGF-β1 expression , 2005, Oncogene.

[2]  X. Zhang,et al.  Mammary Cells with Active Wnt Signaling Resist ErbB2-Induced Tumorigenesis , 2013, PloS one.

[3]  J. Rosen,et al.  Stem/Progenitor Cells in Mouse Mammary Gland Development and Breast Cancer , 2005, Journal of Mammary Gland Biology and Neoplasia.

[4]  S. Hilsenbeck,et al.  Keratin 6a marks mammary bipotential progenitor cells that can give rise to a unique tumor model resembling human normal-like breast cancer , 2011, Oncogene.

[5]  L. Hennighausen,et al.  Mammary epithelial cells undergo secretory differentiation in cycling virgins but require pregnancy for the establishment of terminal differentiation. , 1995, Development.

[6]  N. Evans,et al.  The Wnt Signaling Receptor Lrp5 Is Required for Mammary Ductal Stem Cell Activity and Wnt1-induced Tumorigenesis* , 2006, Journal of Biological Chemistry.

[7]  J. Russo,et al.  Differentiation of the mammary gland and susceptibility to carcinogenesis , 2005, Breast Cancer Research and Treatment.

[8]  P. Hinds,et al.  Cyclin D1 kinase activity is required for the self-renewal of mammary stem and progenitor cells that are targets of MMTV-ErbB2 tumorigenesis. , 2010, Cancer cell.

[9]  H. Varmus,et al.  Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[10]  L. Hennighausen,et al.  An adjunct mammary epithelial cell population in parous females: its role in functional adaptation and tissue renewal. , 2002, Development.

[11]  S. Hilsenbeck,et al.  Mechanism and preclinical prevention of increased breast cancer risk caused by pregnancy , 2013, eLife.

[12]  Nisha M. Badders,et al.  The Wnt Receptor, Lrp5, Is Expressed by Mouse Mammary Stem Cells and Is Required to Maintain the Basal Lineage , 2009, PloS one.

[13]  H. Varmus,et al.  Introduction of oncogenes into mammary glands in vivo with an avian retroviral vector initiates and promotes carcinogenesis in mouse models , 2006, Proceedings of the National Academy of Sciences.

[14]  L. Donehower,et al.  Defining the ATM-mediated barrier to tumorigenesis in somatic mammary cells following ErbB2 activation , 2010, Proceedings of the National Academy of Sciences.

[15]  T. Deng,et al.  Identification of tumorsphere- and tumor-initiating cells in HER2/Neu-induced mammary tumors. , 2007, Cancer research.

[16]  W. Hahn,et al.  TRAF2 is an NF-κB activating oncogene in epithelial cancers , 2013, Oncogene.

[17]  A. Triplett,et al.  Parity-induced mammary epithelial cells facilitate tumorigenesis in MMTV-neu transgenic mice , 2004, Oncogene.

[18]  François Vaillant,et al.  Steroid hormone receptor status of mouse mammary stem cells. , 2006, Journal of the National Cancer Institute.

[19]  Marie-Liesse Asselin-Labat,et al.  Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation , 2007, Nature Cell Biology.

[20]  S. Haricharan,et al.  STAT signaling in mammary gland differentiation, cell survival and tumorigenesis , 2014, Molecular and Cellular Endocrinology.

[21]  S. Hilsenbeck,et al.  Somatic expression of PyMT or activated ErbB2 induces estrogen-independent mammary tumorigenesis. , 2010, Neoplasia.